Gilead Sciences Inc(GILD)

66.54

Change: 0 (0)

As of Sun 05/09/2021 03:01 AM

% Of Value

Growth

Value Per Share

:

:

:

143.99

-15.24

46.2100 (as of 19/07/2019)

NO DATA TO DISPLAY
NO DATA TO DISPLAY
NO DATA TO DISPLAY
NO DATA TO DISPLAY

Fundamentals Data

Open 67.80 Dividend 1358
Close Price 66.54 DivYield 2.42 %
High 67.83 Growth -3.9 B
Low 66.66 Growth% -15.24
P/e 15.28 Volume 5.7 M
P/b 11.39 Market Capital 83.3 B
Highest High 85.47 Lowest Low 64.12
50 Days Moving Average 65.95 (as of 03/07/2019) 50 Days Moving Average Percentage -5.904 (as of 03/07/2019)
Industry: Biotechnology: Biological Products (No Diagnostic Substances)

Charts for balance Sheet:

Balance Sheet Table: last 5 years

Note: Numbers are estimated, Exact figures can be found in Annual Reports
Type Year1 / 2014 Year2 / 2015 Year3 / 2016 Year4 / 2017 Current Year / 2018
Revenue 24.8 B 32.6 B 30.3 B 26.1 B 22.1 B
Cap Spending -557.0 M -747.0 M -748.0 M -590.0 M -924.0 M
Operating Expenses 5.8 B 6.4 B 8.4 B 7.6 B 9.0 B
Operating Cash Flow 15.2 B 22.1 B 17.6 B 14.1 B 8.2 B
Free Cash Flow 12.2 B 19.5 B 15.9 B 11.3 B 7.4 B
Free Cash Flow Per Share 8.056 13.376 11.89 8.652 5.76
Total liabilities 12.4 B 22.1 B 26.3 B 33.5 B 27.3 B
Total cash 10.0 B 12.8 B 8.2 B 7.5 B 17.9 B
ROE% 0.828 1.043 0.835 0.209 0.252
Outstanding Shares 1.4 B 1.3 B 1.3 B 1.3 B 1.2 B
P/E 12.853 6.745 6.825 22.746 15.28
P/S 6.249 3.742 3.032 4.032 3.767
Revenue USD 24.8 B 32.6 B 30.3 B 26.1 B 22.1 B

Reports for GILD

Date Author Title Action
2020-09-08 stanko Gilead Sciences equity, debt and subsidiaries view
2016-10-13 stanko gilead is the leader of hep C drugs and 14 brand names with 1/3 of market cap in debt view

Latest Searches

Stock Close Price %of value Date